Free Trial

Apellis Pharmaceuticals (APLS) SEC Filings & 10K Form

Apellis Pharmaceuticals logo
$22.95 +0.61 (+2.73%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$22.98 +0.03 (+0.11%)
As of 08/1/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Apellis Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/31/2025
5:52 AM
Apellis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2025
3:56 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2025
3:10 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2025
3:11 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
3:50 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
6:09 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
7:49 AM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
9:38 AM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2025
3:10 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
3:15 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:05 PM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2025
10:46 AM
Apellis Pharmaceuticals (Issuer)
Boucher Kelley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
10:44 AM
Apellis Pharmaceuticals (Issuer)
Boucher Kelley (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/22/2025
12:19 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
3:42 PM
Apellis Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
Form SCHEDULE 13G
05/12/2025
1:22 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2025
6:01 AM
Apellis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2025
6:33 AM
Apellis Pharmaceuticals (Filer)
Form DEF 14A
04/23/2025
6:35 AM
Apellis Pharmaceuticals (Filer)
Form DEFA14A
04/23/2025
6:36 AM
Apellis Pharmaceuticals (Filer)
Form ARS
04/21/2025
3:23 PM
Apellis Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
6:11 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
11:27 AM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
2:18 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
6:22 AM
Apellis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2025
6:00 AM
Apellis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
12:59 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
2:13 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
9:49 AM
Apellis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
02/03/2025
12:09 PM
Apellis Pharmaceuticals (Subject)
MORGAN STANLEY (Filed by)
Form SCHEDULE 13G
01/30/2025
11:13 AM
Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:15 AM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:18 AM
Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:20 AM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:01 AM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:03 AM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:07 AM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:10 AM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:12 AM
Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
2:42 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:18 PM
Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump’s national nightmare is here (Ad)

Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.

Watch the National Emergency broadcast here
01/29/2025
2:22 PM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:26 PM
Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:11 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:12 PM
Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:16 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:16 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:17 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2025
2:37 PM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:39 PM
Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:41 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:23 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:25 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:26 PM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:28 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:29 PM
Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:31 PM
Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:19 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:00 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:39 PM
Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:42 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:43 PM
Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:44 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:45 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:45 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:51 PM
Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:52 PM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:56 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
2:56 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
2:59 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
2:54 PM
Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
3:38 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
3:20 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
3:27 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
3:29 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
3:22 PM
Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:25 PM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:29 PM
Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:30 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:09 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:10 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:14 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:15 PM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:55 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
4:56 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:00 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:02 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:02 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:05 PM
Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:07 PM
Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:09 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Market Crash Warning: How to Protect Your Wealth Before August 12th (Ad)

China tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alternative Assets reveals 3 urgent moves to protect your portfolio, plus the #1 asset class thriving during crises (hint: it’s not stocks or bonds).

Get your FREE Tariff Crash Escape Plan now
01/13/2025
5:13 PM
Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:15 PM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
8:08 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
4:38 PM
Apellis Pharmaceuticals (Issuer)
Walbert Keli (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2025
4:39 PM
Apellis Pharmaceuticals (Issuer)
Walbert Keli (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:03 PM
Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
2:17 PM
Apellis Pharmaceuticals (Subject)
Baumal Caroline (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2024
3:06 PM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:15 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:APLS) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners